An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medicine

Last updated: March 2, 2026
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoarthritis

Knee Injuries

Treatment

Follow-ups

Genetic screening

Multifaceted diagnostic assessments

Clinical Study ID

NCT06634654
179.24 CET2 cbm
PNRR-MCNT2-2023-12378237
  • Ages > 18
  • All Genders

Study Summary

Goal: The goal of this interventional study is to understand how multimodal preoperative data can predict outcomes after Total Knee Arthroplasty (TKA) and improve personalized medicine practices.

Participant Population: The study will enroll 197 patients suffering from symptomatic, end-stage knee osteoarthritis, who are above 18 years old and have functionally intact ligaments.

Main Questions:

  • Can multimodal preoperative data, genetic predisposition, and psycho-behavioral characteristics predict outcomes after TKA?

  • Can AI models effectively use this data to customize prostheses and surgical interventions, and predict patient outcomes? Comparison Group Information (If applicable): Not specified in the provided details.

Participant Tasks:

  • Undergo TKA as per the normal clinical routine.

  • Participate in pre- and post-surgical follow-ups including:

  • Clinical-functional assessments.

  • Administration of clinical scores.

  • Collection of biological samples.

  • Biomechanical analysis using a stereophotogrammetric system.

  • Provide data for the comprehensive multimodal indexed database.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Symptomatic, end-stage knee osteoarthritis

  2. Ligaments functionally intact

  3. Age: older than18 years old

Exclusion

Exclusion Criteria:

  1. Neurological or other conditions affecting patients ability to join walking trials

  2. Inflammatory or infectious arthritis

  3. Previous articular fracture or knee surgery (excluding knee arthroscopy and meniscalsurgery)

  4. Active tumors or pregnancy.

Study Design

Total Participants: 197
Treatment Group(s): 4
Primary Treatment: Follow-ups
Phase:
Study Start date:
October 14, 2024
Estimated Completion Date:
December 31, 2029

Study Description

Osteoarthritis is one of the most common causes of knee disorders, leading to pain, reduced mobility, and a decline in quality of life. Total knee arthroplasty (TKA) is one of the most established treatments for end-stage osteoarthritis. Despite advancements in surgical techniques, patient dissatisfaction remains high. After surgery, patients often experience swelling, pain, and difficulty with daily activities. Revision surgery is a major challenge, with aseptic loosening occurring in 15-20% of cases. Given the high disability rates and healthcare costs associated with TKA, optimizing patient care is crucial.

Artificial intelligence (AI) offers the potential to identify new care profiles. For the first time, AI can integrate multimodal datasets. This approach could lead to personalized treatment for knee osteoarthritis patients, in line with precision medicine principles. This study takes a multidisciplinary approach to better understand the causes of failure and dissatisfaction following TKA.

The primary aim of this study is is to create a multimodal database. This database will include structural, genetic, biomechanical, clinical, psychological, biological, stress-related, inflammatory, and demographic data. Using AI, the study aims to build predictive models for post-TKA outcomes. Insights from this research could improve patient management and lead to new therapeutic approaches.

Patients suffering from knee osteoarthritis at Fondazione Policlinico Universitario Campus Bio-Medico will be enrolled in this study if they meet the inclusion/exclusion criteria described above.

There are no risks for the patients recruited in the study. The total duration of the study is 5 years. The enrolment of patients will start on the 01/10/2024 and will last 12 months for each patient.

The Italian Ministry of Health and the Fondazione Policlinico Universitario Campus Bio-Medico supported this study.

The PI and also the main contact of this study is professor Umile Giuseppe Longo.

Connect with a study center

  • Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy 00128
    Italy

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.